Dermatological complications in children and adolescents that are related to continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) have not been well‐characterized. This study examined the prevalence and… Click to show full abstract
Dermatological complications in children and adolescents that are related to continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) have not been well‐characterized. This study examined the prevalence and characteristics of different types of dermatological complications.
               
Click one of the above tabs to view related content.